Features

Top 25 Pharma and Biopharma Report

(Based on 2014 Sales, in $U.S. Millions)

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Top 25 Pharma and Biopharma Companies (Based on 2014 Sales, in $U.S. Millions)

1.  Novartis $57,996
2. Pfizer $45,708
3. Sanofi  $41,047
4. Roche $37,082
5. Merck $36,042
6. Johnson & Johnson  $32,313
7.  GlaxoSmithKline $30,806
8.  AstraZeneca $26,095
9.  Gilead Sciences $24,890
10. Teva $20,272
11. Amgen $20,063
12. AbbVie  $19,960
13. Eli Lilly & Co $19,615
14. Takeda $16,424
15.  Bristol-Myers Squibb $15,879
16.  Bayer $14,649
17. Novo Nordisk  $14,497
18. Actavis (Allergan)  $13,062
19. Boehringer Ingelheim  $12,887
20.  Merck Serono $11,501
21.  Otsuka $10,207
22. Biogen $9,703
23.  Mylan $7,720
24. Baxter Bioscience $6,699
25.  Eisai $4,584

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters